Expected in First Half of 2026, with Topline Data Expected in Second Half of 2026 On Track to Initiate Second Phase 3 Study, ...

Heart failure (HF) remains a significant cardiovascular public health concern in India, affecting an estimated 1.3 to 22.7 ...

A new study published in the European Journal of Medical Research revealed that dapagliflozin, a sodium-glucose ...

US-based Cardurion Pharmaceuticals has completed enrolment in two multi-centre, global Phase II CYCLE trials of the ...

For the first time, a scientific statement on prevention of heart failure has been released. The statement from the Heart ...

There is lower risk for recurrent HF hospitalization in older patients that receive SGLT2is following acute decompensated heart failure.

Japanese registry data point to fewer deaths and heart failure hospitalizations, especially when MR is reduced to mild or ...

Left bundle branch block may serve as an important indicator for asymptomatic individuals predisposed to heart failure.

Cardiosense says its CardioTag device is the first wearable sensor that simultaneously captures high-fidelity ECG, PPG and SCG signals ...

Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Novo Nordisk is conducting a Phase 2 study titled ‘A Research Study ...

Early symptoms like fatigue, breathlessness, swelling mimic common heart issues, causing cardiac amyloidosis to go undetected ...

"Pharmacotherapy can help people living with obesity improve overall health, not just lose weight," says Dr. Sue D. Pedersen, ...